tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

RARE Stock Latest News

Ultragenyx: 1st patient dosed in Aspire studyof GTX-102 for Angelman treatment
The FlyUltragenyx: 1st patient dosed in Aspire studyof GTX-102 for Angelman treatment
2d ago
RARE
Ultragenyx submits BLA to FDA for UX111
PremiumThe Fly
Ultragenyx submits BLA to FDA for UX111
2d ago
RARE
Ultragenyx price target lowered to $102 from $105 at JPMorgan
PremiumThe Fly
Ultragenyx price target lowered to $102 from $105 at JPMorgan
1M ago
RARE
Ultragenyx participates in a conference call with JPMorgan
PremiumThe Fly
Ultragenyx participates in a conference call with JPMorgan
1M ago
RARE
Ultragenyx price target raised to $121 from $109 at Canaccord
PremiumThe Fly
Ultragenyx price target raised to $121 from $109 at Canaccord
2M ago
RARE
Ultragenyx price target raised to $95 from $82 at H.C. Wainwright
PremiumThe FlyUltragenyx price target raised to $95 from $82 at H.C. Wainwright
2M ago
RARE
3 Best Stocks to Buy Now, 11/6/2024, According to Top Analysts 
Premium
Market News
3 Best Stocks to Buy Now, 11/6/2024, According to Top Analysts 
2M ago
DIN
MCHP
Ultragenyx Reports Strong Q3 Growth and Milestones
Premium
Company Announcements
Ultragenyx Reports Strong Q3 Growth and Milestones
2M ago
RARE
Ultragenyx reports Q3 EPS ($1.40), consensus ($1.45)
PremiumThe Fly
Ultragenyx reports Q3 EPS ($1.40), consensus ($1.45)
2M ago
RARE
Ultragenyx backs FY24 revenue view $530M-$550M, consensus $536.8M
PremiumThe Fly
Ultragenyx backs FY24 revenue view $530M-$550M, consensus $536.8M
2M ago
RARE
Is RARE a Buy, Before Earnings?
PremiumPre-Earnings
Is RARE a Buy, Before Earnings?
2M ago
RARE
Ultragenyx management to meet with Cantor Fitzgerald
PremiumThe Fly
Ultragenyx management to meet with Cantor Fitzgerald
2M ago
RARE
Ultragenyx price target raised to $73 from $61 at TD Cowen
PremiumThe FlyUltragenyx price target raised to $73 from $61 at TD Cowen
2M ago
RARE
Ultragenyx price target raised to $83 from $73 at BofA
Premium
The Fly
Ultragenyx price target raised to $83 from $73 at BofA
2M ago
RARE
Inozyme appoints Erik Harris to board of directors
Premium
The Fly
Inozyme appoints Erik Harris to board of directors
3M ago
INZY
RARE
Ultragenyx receives Breakthrough Therapy Designation for setrusumab
PremiumThe Fly
Ultragenyx receives Breakthrough Therapy Designation for setrusumab
3M ago
RARE
Ultragenyx provides update on Cyprus2+ study, to submit protocol amendment
PremiumThe Fly
Ultragenyx provides update on Cyprus2+ study, to submit protocol amendment
3M ago
RARE
Closing Bell Movers: Ultragenyx Pharmaceutical slips 2% on study update
PremiumThe Fly
Closing Bell Movers: Ultragenyx Pharmaceutical slips 2% on study update
3M ago
PEV
IRIX
Passage Bio appoints Tom Kassberg to board of directors
PremiumThe Fly
Passage Bio appoints Tom Kassberg to board of directors
3M ago
PASG
RARE
Truist biotech analysts hold an analyst/industry conference call
PremiumThe FlyTruist biotech analysts hold an analyst/industry conference call
4M ago
IONS
RARE
Abeona Therapeutics appoints Zeiher, Crombez to board of directors
Premium
The Fly
Abeona Therapeutics appoints Zeiher, Crombez to board of directors
4M ago
ABEO
RARE
Ultragenyx price target lowered to $81 from $83 at Barclays
Premium
The Fly
Ultragenyx price target lowered to $81 from $83 at Barclays
5M ago
RARE

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >